Nasus Pharma to Participate in Upcoming Investor Conferences
Summary
TEL AVIV, Israel, May 01, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ('Nasus Pharma' or the 'Company'), a clinical-stage pharmaceutical company fo...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.